Joseph Michael Warusz - Net Worth and Insider Trading

Joseph Michael Warusz Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joseph Michael Warusz owns 3 companies in total, including Adynxx Inc (ADYX) , Soligenix Inc (SNGX) , and NovaDel Pharma Inc (NVDL) .

Click here to see the complete history of Joseph Michael Warusz’s form 4 insider trades.

Insider Ownership Summary of Joseph Michael Warusz

Ticker	Comapny	Transaction Date	Type of Owner
ADYX	Adynxx Inc	2018-04-01	Chief Financial Officer
SNGX	Soligenix Inc	2011-05-31	VP of Admin & Controller & other: Princ Accounting Officer
NVDL	NovaDel Pharma Inc	2009-03-25	Principal Accounting Officer

Joseph Michael Warusz Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Joseph Michael Warusz Ownership Network

Ownership Network List of Joseph Michael Warusz

No Data

Ownership Network Relation of Joseph Michael Warusz

Joseph Michael Warusz Owned Company Details

What does Adynxx Inc do?

Who are the key executives at Adynxx Inc?

Joseph Michael Warusz is the Chief Financial Officer of Adynxx Inc. Other key executives at Adynxx Inc include 10 percent owner David Bonderman , CHIEF MEDICAL OFFICER Donald C. Manning , and 10 percent owner Domain Partners Viii, L.p. .

Adynxx Inc (ADYX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Adynxx Inc (ADYX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adynxx Inc (ADYX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Adynxx Inc (ADYX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Adynxx Inc Insider Transactions

No Available Data

What does Soligenix Inc do?

Who are the key executives at Soligenix Inc?

Joseph Michael Warusz is the VP of Admin & Controller & other: Princ Accounting Officer of Soligenix Inc. Other key executives at Soligenix Inc include CMO Richard Straube , director & Chairman & CEO and President Christopher Schaber , and Chief Financial Officer Jonathan L. Guarino .

Soligenix Inc (SNGX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Soligenix Inc (SNGX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Soligenix Inc (SNGX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Soligenix Inc (SNGX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Soligenix Inc Insider Transactions

No Available Data

What does NovaDel Pharma Inc do?

Who are the key executives at NovaDel Pharma Inc?

Joseph Michael Warusz is the Principal Accounting Officer of NovaDel Pharma Inc. Other key executives at NovaDel Pharma Inc include 10 percent owner Jay Moorin , 10 percent owner Proquest Investments Ii Advisors Fund Lp , and 10 percent owner Proquest Investments Ii Lp .

NovaDel Pharma Inc (NVDL) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of NovaDel Pharma Inc (NVDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NovaDel Pharma Inc (NVDL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NovaDel Pharma Inc (NVDL)'s detailed insider trading history can be found in Insider Trading Tracker table.

NovaDel Pharma Inc Insider Transactions

No Available Data

Joseph Michael Warusz Mailing Address

Above is the net worth, insider trading, and ownership report for Joseph Michael Warusz. You might contact Joseph Michael Warusz via mailing address: 12 Teal Drive, Langhorne Pa 19047.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.